European biotech is seeing both encouraging momentum and challenges. Innovation from European academia continues to inspire therapeutic concepts.
ADVERTISEMENT
Tag Archive for: Kurma Partners
German iRhom2-targeted antibody specialist SciRhom GmbH has closed an oversubscribed €63m Series A financing that will be used to provide clinical proof of concept in autoimmune disorders.


Kurma Partners